Aeryn, 25, is a delightful young woman who
loves to read, watch television, and movies; is terrified of needles, clowns and spiders; and blogs by the tagline, "I live in my own little world, but that's okay,
everyone knows me here." In July 2004, she was having gynecological problems and her family physician spent the
next few months treating her with hormones and medications, but nothing seemed to help. After seeing a specialist, and
having a biopsy, she was diagnosed with cervical cancer. When you are 25, a cancer diagnosis is time out of sequence.
Aeryn felt her world stopped that day. With her grandmother, mother, husband and cat by her side, she made it through
chemotherapy and radiation. Her last tests in December show no signs of cancer. Aeryn blogs about cervical cancer
survivorship and all the events of daily life with an endearing presence here in the blogosphere.Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
Posts with tag GynecologicalCancers
Aeryn blogs cervical cancer survivorship
Aeryn, 25, is a delightful young woman who
loves to read, watch television, and movies; is terrified of needles, clowns and spiders; and blogs by the tagline, "I live in my own little world, but that's okay,
everyone knows me here." In July 2004, she was having gynecological problems and her family physician spent the
next few months treating her with hormones and medications, but nothing seemed to help. After seeing a specialist, and
having a biopsy, she was diagnosed with cervical cancer. When you are 25, a cancer diagnosis is time out of sequence.
Aeryn felt her world stopped that day. With her grandmother, mother, husband and cat by her side, she made it through
chemotherapy and radiation. Her last tests in December show no signs of cancer. Aeryn blogs about cervical cancer
survivorship and all the events of daily life with an endearing presence here in the blogosphere.New drug treatment for advanced cervical cancer
GlaxoSmithKline has announced that the U.S. Food and Drug Administration
granted a priority review for Hycamtin, as a treatment for advanced cervical cancer that has not been cured by surgery
or radiation therapies. Currently, Hycamtin is administered in the treatment of metastatic ovarian and lung cancer. The
priority review means that the drug could be approved in the treatment for advanced cervical cancer in as little as six
months. In the United States, cervical cancer is the third most common gynecological cancer among women, with close to
12,000 new cases diagnosed annually. For more information on advanced cervical cancer, Relapsed Ovarian Cancer, is a booklet
offered as a PDF download.
